The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Endopath-F
Agnus, Angelica sin, Cimicifuga, Fucus, Glandula suprarenalis suis, Glycyrrhiza, Hypothalamus, Oophorinum, Pituitarum posterium, Pulsatilla, Sepia, Thyroidinum, Xanthoxylum · CHASTE TREE FRUIT 4 [hp_X]/59.1mL; ANGELICA SINENSIS ROOT 8 [hp_X]/59.1mL; BLACK COHOSH 4 [hp_X]/59.1mL; FUCUS VESICULOSUS 4 [hp_X]/59.1mL; SUS SCROFA ADRENAL GLAND 9 [hp_X]/59.1mL; LICORICE 4 [hp_X]/59.1mL; BOS TAURUS HYPOTHALAMUS 12 [hp_X]/59.1mL; SUS SCROFA OVARY 9 [hp_X]/59.1mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 12 [hp_X]/59.1mL; PULSATILLA VULGARIS 12 [hp_X]/59.1mL; SEPIA OFFICINALIS JUICE 12 [hp_X]/59.1mL; THYROID, UNSPECIFIED 9 [hp_X]/59.1mL; ZANTHOXYLUM AMERICANUM BARK 4 [hp_X]/59.1mL · Liquid · Oral · Energetix Corporation
NDC 64578-0170-01 · 59.1 mL in 1 BOTTLE · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Agnus, Angelica sin, Cimicifuga, Fucus, Glandula suprarenalis suis, Glycyrrhiza, Hypothalamus, Oophorinum, Pituitarum posterium, Pulsatilla, Sepia, Thyroidinum, Xanthoxylum (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Energetix Corporation | CHASTE TREE FRUIT 4 [hp_X]/59.1mL; ANGELICA SINENSIS ROOT 8 [hp_X]/59.1mL; BLACK COHOSH 4 [hp_X]/59.1mL; FUCUS VESICULOSUS 4 [hp_X]/59.1mL; SUS SCROFA ADRENAL GLAND 9 [hp_X]/59.1mL; LICORICE 4 [hp_X]/59.1mL; BOS TAURUS HYPOTHALAMUS 12 [hp_X]/59.1mL; SUS SCROFA OVARY 9 [hp_X]/59.1mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 12 [hp_X]/59.1mL; PULSATILLA VULGARIS 12 [hp_X]/59.1mL; SEPIA OFFICINALIS JUICE 12 [hp_X]/59.1mL; THYROID, UNSPECIFIED 9 [hp_X]/59.1mL; ZANTHOXYLUM AMERICANUM BARK 4 [hp_X]/59.1mL | Aug 26, 2026 | Sep 2, 2026 |
| Energetix Corporation | CHASTE TREE FRUIT 8 [hp_X]/59.1mL; ANGELICA SINENSIS ROOT 4 [hp_X]/59.1mL; BLACK COHOSH 12 [hp_X]/59.1mL; FUCUS VESICULOSUS 4 [hp_X]/59.1mL; SUS SCROFA ADRENAL GLAND 4 [hp_X]/59.1mL; LICORICE 4 [hp_X]/59.1mL; BOS TAURUS HYPOTHALAMUS 12 [hp_X]/59.1mL; SUS SCROFA OVARY 12 [hp_X]/59.1mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 9 [hp_X]/59.1mL; PULSATILLA VULGARIS 9 [hp_X]/59.1mL; SEPIA OFFICINALIS JUICE 12 [hp_X]/59.1mL; THYROID, UNSPECIFIED 9 [hp_X]/59.1mL; ZANTHOXYLUM AMERICANUM BARK 4 [hp_X]/59.1mL | Jul 22, 2026 | Aug 19, 2026 |
| Energetix Corporation | ANGELICA SINENSIS ROOT 8 [hp_X]/59.1mL; BLACK COHOSH 4 [hp_X]/59.1mL; BOS TAURUS HYPOTHALAMUS 12 [hp_X]/59.1mL; CHASTE TREE FRUIT 4 [hp_X]/59.1mL; FUCUS VESICULOSUS 4 [hp_X]/59.1mL; LICORICE 4 [hp_X]/59.1mL; PULSATILLA VULGARIS 12 [hp_X]/59.1mL; SEPIA OFFICINALIS JUICE 12 [hp_X]/59.1mL; SUS SCROFA ADRENAL GLAND 9 [hp_X]/59.1mL; SUS SCROFA OVARY 9 [hp_X]/59.1mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 12 [hp_X]/59.1mL; THYROID, UNSPECIFIED 9 [hp_X]/59.1mL; ZANTHOXYLUM AMERICANUM BARK 4 [hp_X]/59.1mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Endopath-F — NDC 64578-0170-01," retrieved September 3, 2026, https://drugdashboards.com/drug/64578017001.
Free to cite with attribution — see how the data is put together.